Please try another search
RBC Capital analyst Sean Dodge maintained a Buy rating on Tabula Rasa HealthCare (NASDAQ:TRHC) on Sunday, setting a price target of $70, which is approximately 37.07% above the present share price of $51.07.
Dodge expects Tabula Rasa HealthCare to post earnings per share (EPS) of -$0.85 for the second quarter of 2021.
The current consensus among 5 TipRanks analysts is for a Moderate Buy rating of shares in Tabula Rasa HealthCare, with an average price target of $52.8.
The analysts price targets range from a high of $70 to a low of $45.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $76.68 million and a net profit of -$16.75 million. The company's market cap is $1.27 billion.
According to TipRanks.com, RBC Capital analyst Sean Dodge is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 12.1% and a 57.14% success rate.
Tabula Rasa Healthcare, Inc. engages in the development of pharmaceutical software that optimizes medication regimens. It offers cloud-based applications, such as EireneRx and MedWise Advisor. The company was founded by Calvin H. Knowlton and Orsula V. Knowlton in April 2009 and is headquartered in Moorestown, NJ.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.